3/16/2009

Baxter International announced that the FDA has assigned the company's warning letter over its Colleague Volumetric Infusion pumps, which have been found to overheat or shut down while delivering intravenous fluids and drugs to patients, as a Class I recall. Baxter is not required to withdraw the products from the market, however.

Full Story:
Forbes

Related Summaries